worried patient talking to doctor

Image source: Adobe Stock/WavebreakmediaMicro

News • Conveying probability

“You (might) have cancer” – Pitfalls in doctor-patient communication

A new study from the Ludwig-Maximilian-Universität (LMU) in Munich reveals: Whether patients are able to correctly assess risks depends partly on how physicians convey statistical information to them.

Medical results are not always easy to understand – and the risk statements that come with them perhaps even less so. Communicating statistical information to patients is no easy task. A team of scientists from the domains of medicine, medical education, and mathematics education at LMU has published a study in the journal PLOS ONE investigating how communication between doctors and patients about actual risks can be made more effective.

If the data is difficult for the doctor to interpret, it’s even harder to communicate the information accurately to patients in a way they will understand

Karin Binder

After all, it is not always easy to grasp what certain numbers really mean. “Even doctors sometimes have difficulties in determining the right predictive value. And if the data is difficult for the doctor to interpret, it’s even harder to communicate the information accurately to patients in a way they will understand,” says mathematics educationalist Karin Binder, one of the authors of the study. 

The following case serves to examplify: A patient has just received a conspicuous sonographic finding of his thyroid. Does this mean he has thyroid cancer? Not necessarily, because there is a certain probability that the result of the examination will be positive even though the patient does not have thyroid cancer. To explain to patients what the statistical picture looks like after such a positive test result, there are two approaches. One of them requires some lateral thinking, while the other is much easier to interpret from the patient’s perspective, as the researchers were able to demonstrate.

The commonly used Bayesian approach proceeds from the number of patients who actually have the disease. First of all, the doctor explains how frequently the disease occurs overall – for example: “out of 1,000 patients, 50 have thyroid cancer.” Then the doctor lays out: 

  1. for how many of these patients with thyroid cancer, the test result is positive (20 out of 50) and 
  2. how many people who do not have thyroid cancer nonetheless have a positive test result (110 out of the remaining 950). 

This is generally the information the doctor either knows or can easily research. Positive tests as a proportion of people with the disease is also known as sensitivity – a term we may be familiar with from the Covid-19 pandemic, when it was used, for example, as a quality criterion for rapid tests. Unfortunately, however, positive tests as a proportion of people with the disease is often confused with people with the disease as a proportion of positive tests! And these two percentages can greatly differ depending on the situation. 

So what do the numbers quoted above mean in relation to a person with a positive test result? How many people who test positive actually have the disease? If for you the answer is not immediately apparent, you are not alone: Without further information, only 10% of participants were able to calculate how many people with positive results actually had the disease.

With Bayesian communication, participants were considerably slower in reaching the correct result, if they got there at all. And in busy doctor’s offices and hospitals, this time is often not available

Karin Binder

“Diagnostic” communication of information proceeds very differently: First of all, the doctor explains how many patients have positive test results, irrespective of whether they actually have the disease or not. In our example, this would be 130 people with a conspicuous thyroid ultrasound (out of 1,000 people examined). Next, the doctor explains how many of these people with positive tests actually have the disease (20 out of 130) and how many of the people with negative test results have the disease (30 out of 870). 

The relevant information is contained here directly and without the need for mental arithmetic: If my result is positive, then the probability is a 20 out of 130 that I actually have thyroid cancer. When communicated in this form, 72% of study participants were capable of arriving at this conclusion, compared to 10% with the Bayesian approach.

“With Bayesian communication, moreover, participants were considerably slower in reaching the correct result, if they got there at all,” says Karin Binder. “And in busy doctor’s offices and hospitals, this time is often not available.” The team of authors therefore calls on doctors to use diagnostic information communication more readily in future. This would go some way to avoiding confusion, misinterpretation, and wrong decisions.

It would be even better, however, to take the time to give patients a full picture of the situation, containing both diagnostic and Bayesian information. Only this can explain the surprising phenomenon whereby even a medical test with outstanding quality criteria can have very limited predictive power under certain circumstances (e.g., routine screenings).


Source: Ludwig-Maximilians-Universität München

14.06.2023

Related articles

Photo

News • Human papillomavirus infection

Cervical cancer: improved screening through HPV risk groups

Analyses of self-tests for human papillomavirus (HPV) can be used to divide HPV-positive women into three risk groups, according to a new study. This could enhance cervical cancer screening.

Photo

News • Hyperpolarised carbon-13 imaging

Metabolic MRI imaging distinguishes ovarian cancer subtypes

A new MRI-based imaging technique predicts the response of ovarian cancer tumours to treatment, and rapidly reveals how well treatment is working, in patient-derived cell models.

Photo

News • Cancer treatment advances

USC study findings: early blood test forecasts survival rates in patients with metastatic prostate cancer

A new study found that measuring circulating tumor cells (CTCs), rare cancer cells shed from tumors into the blood, is a reliable way to predict later treatment response and survival prospects with…

Related products

Subscribe to Newsletter